Fatty acids increase glucose uptake and metabolism in C2C12 myoblasts stably transfected with human lipoprotein lipase.

American Journal of Physiology. Endocrinology and Metabolism
Warren H CapellR H Eckel

Abstract

Cellular effects of FFA might differ from those of lipoprotein triglyceride (TG)-derived fatty acids (TGFA). The aim of the current study was to examine the relationship between lipoprotein lipase (LPL) expression, TGFA, or FFA availability and glucose metabolism in the absence of insulin in C2C12 myoblasts. Control myoblasts or myoblasts stably transfected with human lipoprotein lipase (C2/LPL; 15-fold greater LPL activity) were incubated for 12 h in fetal bovine serum-free medium in the absence or presence of Intralipid-20. Intracellular retention of labeled medium glucose was assessed in a subset of experiments. In the presence of Intralipid, medium glucose disappearance was increased in C2/LPL cells but not in control cells. In both cell types, glucose label retention in cellular TG was increased in the presence of Intralipid; incubation with albumin-bound oleate produced similar results. In the presence of Intralipid, the LPL hydrolytic inhibitor tetrahydrolipstatin blocked excess glucose retention in cellular TG but did not significantly decrease glucose disappearance in C2/LPL cells. Changes in glucose transport or hexokinase II did not explain the altered glucose disappearance in C2/LPL cells. Our results suggest that L...Continue Reading

References

Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·U BeisiegelG Bengtsson-Olivecrona
Sep 1, 1990·Metabolism: Clinical and Experimental·C ChambrierM Beylot
Apr 20, 1989·The New England Journal of Medicine·R H Eckel
Nov 1, 1985·The Journal of Clinical Investigation·A D BaronJ M Olefsky
Nov 1, 1983·The Journal of Clinical Investigation·E FerranniniR A DeFronzo
Sep 1, 1995·The Journal of Clinical Investigation·G Boden, X Chen
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y LeeR H Unger
Jun 1, 1994·European Journal of Biochemistry·A LookeneG Olivecrona
Dec 1, 1996·Endocrinology and Metabolism Clinics of North America·T G Ramsay
Aug 14, 1999·The Journal of Biological Chemistry·Z Guo, M D Jensen
Apr 25, 2000·Biochemical and Biophysical Research Communications·P PoirierR H Eckel
Jul 21, 2000·The Journal of Clinical Investigation·G I Shulman
Aug 19, 2000·American Journal of Physiology. Endocrinology and Metabolism·A L ThompsonG J Cooney
Jun 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·J K KimG I Shulman
Jul 11, 2002·The Journal of Clinical Endocrinology and Metabolism·Anneli Seppälä-LindroosHannele Yki-Järvinen
Aug 10, 2002·American Journal of Physiology. Endocrinology and Metabolism·Lori L Tortorella, Paul F Pilch
Feb 6, 2003·The Journal of Clinical Investigation·Hiroaki YagyuIra J Goldberg
Apr 18, 2003·Journal of Lipid Research·Isabel R SchlaepferRobert H Eckel
Aug 1, 1959·Canadian Journal of Biochemistry and Physiology·E G BLIGH, W J DYER
Dec 29, 2005·American Journal of Physiology. Endocrinology and Metabolism·Anja BehaAndreas W Herling
Sep 21, 2007·Nature Reviews. Cancer·Javier A Menendez, Ruth Lupu

❮ Previous
Next ❯

Citations

May 21, 2014·The International Journal of Biochemistry & Cell Biology·Maayan BarneaOren Froy
Jul 12, 2011·Current Opinion in Lipidology

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.